DNA Diagnostics for Schistosomiasis Control

Despite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and...

Full description

Bibliographic Details
Main Authors: Kosala G. Weerakoon, Catherine A. Gordon, Donald P. McManus
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Tropical Medicine and Infectious Disease
Subjects:
DNA
Online Access:http://www.mdpi.com/2414-6366/3/3/81
id doaj-c7c6417af7664e4d88b7a765f26059a5
record_format Article
spelling doaj-c7c6417af7664e4d88b7a765f26059a52020-11-25T01:41:02ZengMDPI AGTropical Medicine and Infectious Disease2414-63662018-08-01338110.3390/tropicalmed3030081tropicalmed3030081DNA Diagnostics for Schistosomiasis ControlKosala G. Weerakoon0Catherine A. Gordon1Donald P. McManus2Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaDespite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and low prevalence areas where schistosomiasis elimination is targeted, case detection requires a test that is highly sensitive. Diagnostic tests with low sensitivity will miss individuals with low infection intensity and these will continue to contribute to transmission, thereby interfering with the efficacy of the control measures operating. Of the many diagnostic approaches undertaken to date, the detection of schistosome DNA using DNA amplification techniques including polymerase chain reaction (PCR) provide valuable adjuncts to more conventional microscopic and serological methods, due their accuracy, high sensitivity, and the capacity to detect early pre-patent infections. Furthermore, DNA-based methods represent important screening tools, particularly in those endemic areas with ongoing control where infection prevalence and intensity have been reduced to very low levels. Here we review the role of DNA diagnostics in the path towards the control and elimination of schistosomiasis.http://www.mdpi.com/2414-6366/3/3/81schistosomiasisdiagnosiscontrol and eliminationDNApolymerase chain reaction
collection DOAJ
language English
format Article
sources DOAJ
author Kosala G. Weerakoon
Catherine A. Gordon
Donald P. McManus
spellingShingle Kosala G. Weerakoon
Catherine A. Gordon
Donald P. McManus
DNA Diagnostics for Schistosomiasis Control
Tropical Medicine and Infectious Disease
schistosomiasis
diagnosis
control and elimination
DNA
polymerase chain reaction
author_facet Kosala G. Weerakoon
Catherine A. Gordon
Donald P. McManus
author_sort Kosala G. Weerakoon
title DNA Diagnostics for Schistosomiasis Control
title_short DNA Diagnostics for Schistosomiasis Control
title_full DNA Diagnostics for Schistosomiasis Control
title_fullStr DNA Diagnostics for Schistosomiasis Control
title_full_unstemmed DNA Diagnostics for Schistosomiasis Control
title_sort dna diagnostics for schistosomiasis control
publisher MDPI AG
series Tropical Medicine and Infectious Disease
issn 2414-6366
publishDate 2018-08-01
description Despite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and low prevalence areas where schistosomiasis elimination is targeted, case detection requires a test that is highly sensitive. Diagnostic tests with low sensitivity will miss individuals with low infection intensity and these will continue to contribute to transmission, thereby interfering with the efficacy of the control measures operating. Of the many diagnostic approaches undertaken to date, the detection of schistosome DNA using DNA amplification techniques including polymerase chain reaction (PCR) provide valuable adjuncts to more conventional microscopic and serological methods, due their accuracy, high sensitivity, and the capacity to detect early pre-patent infections. Furthermore, DNA-based methods represent important screening tools, particularly in those endemic areas with ongoing control where infection prevalence and intensity have been reduced to very low levels. Here we review the role of DNA diagnostics in the path towards the control and elimination of schistosomiasis.
topic schistosomiasis
diagnosis
control and elimination
DNA
polymerase chain reaction
url http://www.mdpi.com/2414-6366/3/3/81
work_keys_str_mv AT kosalagweerakoon dnadiagnosticsforschistosomiasiscontrol
AT catherineagordon dnadiagnosticsforschistosomiasiscontrol
AT donaldpmcmanus dnadiagnosticsforschistosomiasiscontrol
_version_ 1725042910411358208